Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John K Field

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Journal of Surgical Oncology|September 3, 2013
The contribution of risk prediction models to early detection of lung cancerJohn K Field, Ying Chen, Michael W Marcus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2011
Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosisUrszula Oleksiewicz, Nikoleta Daskoulidou, Triantafillos Liloglou, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2009
Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in EuropeAdrian Cassidy, Jessica Balsan, Aurélien Vesin, et al.
Cancer Research|June 4, 2009
A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 geneGillian G Johnson, Paul D Sherrington, Anthony Carter, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 19, 2008
The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expressionRichard J Shaw, Gillian L Hall, Derek Lowe, et al.
Human Molecular Genetics|May 16, 2006
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancerGeorge Xinarianos, Fiona E McRonald, Janet M Risk, et al.
International Journal of Oncology|April 29, 2016
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction modelMichael W Marcus, Olaide Y Raji, Stephen W Duffy, et al.
BMC Cancer|November 10, 2019
Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature reviewYue I Cheng, Yun Cui Gan, Dan Liu, et al.
International Journal of Cancer|September 5, 2002
p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinomaGeorge Xinarianos, Triantafillos Liloglou, Wendy Prime, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Journal of Surgical Oncology|September 3, 2013
The contribution of risk prediction models to early detection of lung cancerJohn K Field, Ying Chen, Michael W Marcus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2011
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasmaChristoph Kneip, Bernd Schmidt, Anke Seegebarth, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2011
Neuroglobin and myoglobin in non-small cell lung cancer: expression, regulation and prognosisUrszula Oleksiewicz, Nikoleta Daskoulidou, Triantafillos Liloglou, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2009
Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in EuropeAdrian Cassidy, Jessica Balsan, Aurélien Vesin, et al.
Cancer Research|June 4, 2009
A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 geneGillian G Johnson, Paul D Sherrington, Anthony Carter, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 19, 2008
The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expressionRichard J Shaw, Gillian L Hall, Derek Lowe, et al.
Human Molecular Genetics|May 16, 2006
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancerGeorge Xinarianos, Fiona E McRonald, Janet M Risk, et al.
International Journal of Oncology|April 29, 2016
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction modelMichael W Marcus, Olaide Y Raji, Stephen W Duffy, et al.
BMC Cancer|November 10, 2019
Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature reviewYue I Cheng, Yun Cui Gan, Dan Liu, et al.
International Journal of Cancer|September 5, 2002
p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinomaGeorge Xinarianos, Triantafillos Liloglou, Wendy Prime, et al.
Pageof 26